Goodwin Procter LLP advised Vaccitech on the deal, while Davis Polk advised the representatives of the several underwriters.Vaccitech (Nasdaq: VACC) announced its initial public offering in…
Vaccitech’s $110.5 Million Initial Public Offering


Goodwin Procter LLP advised Vaccitech on the deal, while Davis Polk advised the representatives of the several underwriters.Vaccitech (Nasdaq: VACC) announced its initial public offering in…
…